Influence of Tyrphostin AG490 on the expression of diabetes associated markers in human dipocytes

Tyrosine kinase inhibitors (TKi) hold promise as a treatment for a variety of disorders ranging from those in oncology to diseases thought immune mediated. Tyrphostin AG490 is a potent Jak-Stat TKi shown effective in the prevention of allograft transplant rejection, experimental autoimmune disease,...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Immunogenetics
Prif Awduron: Davoodi-Semiromi, Abdoreza, Wasserfall, H. C, Hassanzadeh, A, Cooper-DeHoff, RM, Wabitsch, M, Atkinson, M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2012
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4538928/
https://ncbi.nlm.nih.gov/pubmed/23081744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00251-012-0659-4
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg